PharmaShots | Incisive News in 3 Shots

Subscribe Now

signs

Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China

Marinomed Biotech Signs a License Agreement with Luoxin to Commercialize Budesolv (budesonide nasal spray) in Greater China

October 22, 2021

Sumitomo Dainippon Pharma Signs a Definitive Agreement with BehaVR to Develop and Commercialize PDTs and Wellness Product for CNS Disorders

Sumitomo Dainippon Pharma Signs a Definitive Agreement with BehaVR to Develop and Commercialize PDTs and Wellness Product for CNS...

October 21, 2021

Takeda Signs an Agreement with Calithera to Acquire Sapanisertib and Mivavotinib

Takeda Signs an Agreement with Calithera to Acquire Sapanisertib and Mivavotinib

October 19, 2021

Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program

Ipsen Signs an Exclusive WW Collaboration with Accent to Develop and Commercialize METTL3 Program

October 18, 2021

Takeda Signs an Exclusive License Agreement with Poseida for Novel Non-Viral In Vivo Gene Therapies

Takeda Signs an Exclusive License Agreement with Poseida for Novel Non-Viral In Vivo Gene Therapies

October 13, 2021

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

Spark Signs an Exclusive Global Licensing Agreement with CombiGene for CG01 to Treat Focal Epilepsy

October 13, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us